Sodium hyaluronate facial filler and preparation method thereof

Through low-temperature and high-temperature secondary cross-linking and mechanical stretching technology, a regular three-dimensional grid structure is formed, which solves the problem of uneven cross-linking degree in the existing technology, and improves the anti-enzymatic and long-lasting ability of sodium hyaluronate gel , achieving a more natural filling effect.

CN117258037BActive Publication Date: 2024-12-06BAIHONG HEYI BIOTECHNOLOGY (SUZHOU) CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202311079670.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-08-25
Publication Date
2024-12-06
Estimated Expiration
2043-08-25

AI Technical Summary

Technical Problem

In the existing cross-linking technology of sodium hyaluronate fillers, the degree of cross-linking is uneven, resulting in disordered gel network structure, poor anti-enzymetic ability, short maintenance time, and difficult to achieve uniform and dense filling effect.

Method used

Using low-temperature high-temperature secondary cross-linking combined with mechanical stretching technology, the cross-linking agent first reacts with the cross-linking agent under low temperature conditions to form a cross-linked hyaluronic acid gel precursor, and the molecular chain is affected by biaxial mechanical stretching of X-axis and Y-axis. The force direction is arranged in an orientation, and then secondary cross-linking is performed at high temperature to form a regular three-dimensional grid structure.

Benefits of technology

A sodium hyaluronate gel with a uniform and dense crosslinked network structure was obtained, which enhanced its resistance to enzymatic lysis and durability, achieving a more natural filling effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117258037B_ABST
    Figure CN117258037B_ABST
Patent Text Reader

Abstract

The present invention provides a method for preparing a sodium hyaluronate facial filler, comprising the following steps: (1) reacting a sodium hyaluronate raw material with a first cross-linking agent in an alkaline solution at low temperature to obtain a gel precursor; (2) performing biaxial mechanical stretching on the gel precursor in both the X-axis and the Y-axis to obtain a gridded gel precursor; (3) reacting the gridded gel precursor with a second cross-linking agent in an alkaline solution at high temperature to obtain a sodium hyaluronate gel. The present invention first performs a cross-linking reaction on a sodium hyaluronate raw material and a cross-linking agent under low temperature conditions to obtain a cross-linked hyaluronic acid gel precursor, and then uses mechanical force to perform biaxial bidirectional cyclic stretching so that the hyaluronic acid molecular chains oriented in the X-axis and the Y-axis are cross-arranged to form an ordered grid, and then the gel precursor with regular gridding is subjected to a secondary cross-linking reaction under high temperature conditions to obtain a sodium hyaluronate gel with a stable, ordered, and regular grid structure.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of biomedicine and medical cosmetology technology. Specifically, the present invention relates to a sodium hyaluronate facial filler and a preparation method thereof. Background Art

[0002] As we age, the elasticity and smoothness of the skin decrease, wrinkles and depressions form on the skin surface, and the glossiness decreases. Deep in the face, the amount of subcutaneous fat gradually decreases, and the soft tissue moves downward as a whole due to gravity and muscle action, becoming loose and sagging. More and more people hope to fill the corresponding parts of the face with materials such as fillers or autologous fat by injection or surgery to expand the volume of soft tissue, thereby modifying their skin morphology and improving facial defects in a non-surgical way, thereby alleviating skin aging and other problems.

[0003] Hyaluronic acid is one of the main extracellular matrices. It has no differences between species and tissues and has good biocompatibility. However, since natural hyaluronic acid is easily degraded in the body, it is difficult for natural hyaluronic acid to remain in the body for a long time and it is difficult to exert its excellent physical and chemical properties. This often limits the therapeutic effect of natural hyaluronic acid. In order to obtain sodium hyaluronate fillers with longer maintenance time, hyaluronic acid molecules are usually modified by modification and cross-linking methods. The cross-linked hyaluronic acid gel retains the excellent characteristics of natural molecular compounds such as tolerability, degradability and reversibility, and is an ideal filler.

[0004] Traditional hyaluronic acid cross-linking is mainly under alkaline conditions, and sodium hyaluronate and cross-linking agent react at a certain temperature and time. In this reaction system, sodium hyaluronate molecules (especially high molecular weight hyaluronic acid molecules) are reunited and entangled with each other, presenting irregular and messy thread ball distribution. At this time, the cross-linking agent molecules react randomly with the reunited sodium hyaluronate molecules, resulting in uneven cross-linking degrees at different sites. The mesh structure of the gel presents a state of partial compactness and partial looseness. The disordered and inhomogeneous network structure inside the obtained gel after cross-linking is not conducive to resisting the effects of enzymolysis from the inside of the tissue, external stress, etc. Under the action of enzymes and external forces, the gel network structure is easy to collapse, and the maintenance time is short after implantation into the human body, and the anti-displacement and anti-deformation capabilities are poor.

[0005] In addition, there is a commonly used "one-pot" cross-linking method on the market. Specifically, the hyaluronic acid raw material, cross-linking agent and reaction solvent are mixed in "one pot" and then directly cross-linked. This method also has the significant defect of uneven cross-linking degree, especially for high molecular weight hyaluronic acid molecules, which are partially agglomerated or entangled in a dispersion system with water as the continuous phase. It is difficult for the cross-linking agent molecules to enter the interior of the agglomerated hyaluronic acid molecules, and they only react with the active groups exposed in the outermost layer, resulting in a low degree of gel cross-linking and poor resistance to enzymatic hydrolysis.

[0006] Currently, there is an urgent need for a method for preparing a sodium hyaluronate facial filler with a uniform and dense cross-linked network structure, stronger resistance to enzymatic degradation and a more natural and lasting filling effect. Summary of the invention

[0007] In view of the problems of disordered arrangement of hyaluronic acid molecular chains, low reaction efficiency with crosslinking agent molecules, and uneven crosslinking in the current crosslinking technology, the present invention provides a method for preparing a sodium hyaluronate facial filler. The method of the present invention can prepare a sodium hyaluronate facial filler with a uniform and dense crosslinked network structure, stronger resistance to enzymolysis, and a more natural and lasting filling effect.

[0008] In one aspect, the present invention provides a method for preparing a sodium hyaluronate facial filler, comprising the following steps:

[0009] (1) reacting a sodium hyaluronate raw material with a first cross-linking agent in an alkaline solution at low temperature to obtain a gel precursor;

[0010] (2) performing biaxial mechanical stretching on the gel precursor in both the X-axis and the Y-axis to obtain a gridded gel precursor;

[0011] (3) reacting the gridded gel precursor with a second cross-linking agent in an alkaline solution at high temperature to obtain a sodium hyaluronate gel.

[0012] The inventors of the present application unexpectedly found that the simultaneous mechanical stretching of the X-axis and Y-axis biaxial stretching between low-temperature and high-temperature crosslinking can promote the preferential orientation of the internal molecular chains of the hydrogel along the force direction, and then make the sodium hyaluronate molecular chains oriented in the X-axis and the Y-axis cross-arranged to form an ordered grid. The present invention combines high-low temperature secondary crosslinking and high molecular weight hyaluronic acid molecular chain gridding orderly arrangement technology, and first cross-links the high molecular weight sodium hyaluronate and the cross-linking agent under low temperature conditions to obtain a cross-linked hyaluronic acid gel precursor, and uses mechanical force to perform biaxial bidirectional cyclic stretching (X-axis, Y-axis) to promote the internal molecular chains of the hydrogel to preferentially orient along the force direction, and then make the sodium hyaluronate molecular chains oriented in the X-axis and the Y-axis cross-arranged to form an ordered grid, and then the gel precursor with regular gridding is subjected to secondary high-temperature crosslinking reaction under high temperature conditions to obtain a cross-linked sodium hyaluronate gel with a stable, orderly, and regularized grid structure. The gel has a uniform and dense cross-linked network structure, in which the physical hydrogen bonds and chemical covalent bonds between the sodium hyaluronate molecular chains are evenly distributed in an ordered three-dimensional grid structure, making it more resistant to enzymatic hydrolysis and having a more natural and lasting filling effect.

[0013] Preferably, in the method of the present invention, the low temperature is 2-8°C.

[0014] Preferably, in the method of the present invention, the high temperature is 30-50°C.

[0015] Preferably, in the method described in the present invention, the first crosslinking agent and the second crosslinking agent are each independently selected from one or more of glutaraldehyde, divinyl sulfone, 1,4-butanediol diglycidyl ether, 1,2,7,8-diepoxyoctane and carbodiimide.

[0016] Preferably, in the method of the present invention, the mechanical stretching is performed at a stretching temperature of 2-8°C.

[0017] Preferably, in the method of the present invention, the mechanical stretching is performed at a stretching rate of 10-30 mm / min.

[0018] Preferably, in the method of the present invention, the mechanical stretching is performed under a tensile strain of 500%-1000%.

[0019] Preferably, in the method of the present invention, the mechanical stretching is performed 50-100 times.

[0020] Preferably, in the method of the present invention, the molecular weight of the sodium hyaluronate raw material is 2.0×10 6 Da-4.0×10 6 Da.

[0021] Preferably, in the method described in the present invention, the weight of the sodium hyaluronate raw material accounts for 5-20% of the total weight of the reaction system in step (1).

[0022] Preferably, in the method of the present invention, the reaction in step (1) is carried out for 2-24 hours.

[0023] Preferably, in the method of the present invention, the pH of the alkaline solution in step (1) is greater than 10.

[0024] Preferably, in the method of the present invention, the reaction in step (3) is carried out for 0.5-10 h.

[0025] Preferably, in the method of the present invention, the pH of the alkaline solution in step (3) is greater than 10.

[0026] Preferably, in the method described in the present invention, the method further comprises a step (4) after step (3): cutting the sodium hyaluronate gel obtained in step (3) into block gel, adding it to PBS buffer or physiological saline for cyclic dialysis.

[0027] Preferably, in the method described in the present invention, the method further comprises a step (5) after step (4): crushing and granulating the dialyzed block gel obtained in step (4) to obtain sodium hyaluronate gel particles.

[0028] Preferably, in the method described in the present invention, the method further comprises a step (6) after step (5): filling the sodium hyaluronate gel particles obtained in step (5) into a prefilled syringe under vacuum.

[0029] Preferably, in the method of the present invention, the method further comprises a step (7) after step (6): sterilizing and packaging the product obtained in step (6) to obtain a sodium hyaluronate facial filler.

[0030] In another aspect, the present invention provides a sodium hyaluronate facial filler prepared by the method described in the present invention.

[0031] In a specific embodiment of the present invention, a method for preparing a high molecular weight sodium hyaluronate reticular regular cross-linked facial filler comprises the following steps:

[0032] Step (i): Low temperature cross-linking

[0033] Add the crosslinker to an alkaline solution with a pH value of >10, shake it thoroughly to dissolve it, and then add 5-20% (w / w) of a 2.0×10 6 Da-4.0×10 6 Da of sodium hyaluronate raw materials are mixed evenly and kept warm at 2-8° C. for 2-24 hours to obtain a cross-linked sodium hyaluronate gel precursor.

[0034] Step (ii): Mechanical stretching

[0035] The gel in step (i) is fixed on a biaxial stretching machine and subjected to simultaneous biaxial stretching in the X-axis and Y-axis at a stretching temperature of 2-8° C., a stretching rate of 10-30 mm / min, a stretching strain of 500%-1000% and a stretching cycle number of 50-100.

[0036] Step (iii): High temperature cross-linking

[0037] A cross-linking agent is added to an alkaline solution with a pH value greater than 10, and the mixture is fully shaken to dissolve and obtain a mixed solution. The gel in step (ii) is immersed in the solution and kept warm at 30-50° C. for 0.5-10 h to obtain a cross-linked sodium hyaluronate gel.

[0038] Step (iv): Dialysis

[0039] The sodium hyaluronate gel obtained in step (iii) is cut into blocks of gel of appropriate size, and PBS buffer or physiological saline with a pH of about 7.2-7.6 is added for cyclic dialysis for 24-48 hours, and the dialysate is replaced 10-20 times during the process until the block gel swells to the required weight. The amount of PBS buffer used for purification each time is 50-100 times the mass of the gel.

[0040] Step (v): Grinding

[0041] The block gel after dialysis in step (iv) is crushed and granulated by a colloid mill, wherein the rotation speed of the colloid mill is 11000 rpm-32000 rpm and the crushing times are 1-4 times to obtain sodium hyaluronate gel particles.

[0042] Step (vi): Filling

[0043] The sodium hyaluronate gel particles are filled into a prefilled syringe under vacuum.

[0044] Step (vii): Sterilization

[0045] The obtained pre-filled injectable gel is sterilized and packaged at 121° C. for 8-30 min to obtain a sodium hyaluronate facial filler.

[0046] The present invention has the following beneficial effects:

[0047] (1) The present invention combines high-low temperature secondary cross-linking and high molecular weight hyaluronic acid molecular chain grid-shaped orderly arrangement technology. High molecular weight sodium hyaluronate and a cross-linking agent are first subjected to a cross-linking reaction under low temperature conditions to obtain a cross-linked hyaluronic acid gel precursor. Mechanical force is used to perform biaxial bidirectional cyclic stretching (X-axis, Y-axis) to promote the preferential orientation of the internal molecular chains of the hydrogel along the force direction, thereby making the hyaluronic acid molecular chains oriented along the X-axis and the Y-axis cross-arranged to form an orderly grid. The gel precursor with regular gridding is then subjected to a secondary high temperature cross-linking reaction under high temperature conditions to obtain a cross-linked sodium hyaluronate gel with a stable, orderly, and regular grid structure.

[0048] (2) The sodium hyaluronate gel with grid-like orderly cross-linking in the present invention has a uniform and dense cross-linked network structure, in which the physical hydrogen bonds and chemical covalent bonds between the sodium hyaluronate molecular chains are evenly distributed in the ordered three-dimensional grid structure, so that it has a stronger ability to resist enzymatic hydrolysis and a more natural and lasting filling effect. BRIEF DESCRIPTION OF THE DRAWINGS

[0049] The embodiments of the present invention are described in detail below with reference to the accompanying drawings, wherein:

[0050] Figure 1 It is a schematic diagram of a method of a specific embodiment of the present invention.

[0051] Figure 2 This is a scanning electron microscope image of the cross-linked sodium hyaluronate gel after biaxial stretching in Example 1 of the present invention.

[0052] Figure 3 It is a scanning electron microscope picture of the cross-linked sodium hyaluronate gel after ineffective biaxial stretching in Comparative Example 1 of the present invention. DETAILED DESCRIPTION

[0053] The present invention is further described in detail below in conjunction with specific embodiments. The given examples are only for illustrating the present invention, rather than for limiting the scope of the present invention.

[0054] The sodium hyaluronate raw materials in the following examples and comparative examples were purchased from Bloomage Biotech Co., Ltd.

[0055] Example 1

[0056] This embodiment provides a method for preparing a high molecular weight sodium hyaluronate mesh-like ordered cross-linked facial filler, which comprises the following steps:

[0057] (1) Add 0.1 g of crosslinker 1,4-butanediol diglycidyl ether (BDDE) to 8 ml of 0.6% NaOH solution, shake thoroughly to dissolve, and then add 11% (w / w) sodium hyaluronate raw material (average molecular weight 2.8×10 6 Da), stirred until uniformly dissolved, and cross-linked at 4°C for 24h to obtain a cross-linked sodium hyaluronate gel precursor.

[0058] (2) The obtained gel precursor was fixed on a biaxial stretching machine and subjected to simultaneous biaxial stretching in the X-axis and Y-axis, wherein the stretching temperature was 4° C., the stretching rate was 20 mm / min, the stretching strain was 800%, and the number of cycles was 60.

[0059] (3) Add 0.1 g of crosslinking agent 1,4-butanediol diglycidyl ether (BDDE) to 8 ml of 0.6% NaOH solution, shake thoroughly to dissolve, immerse the biaxially stretched gel precursor, and crosslink at 45° C. for 4 h to obtain a crosslinked sodium hyaluronate gel.

[0060] (4) Cut the cross-linked sodium hyaluronate gel into pieces less than 1 cm 3 The blocks were dialyzed by adding PBS buffer (pH 7.5) which was 80 times the weight of the gel. The dialysis was continued for 24 h and the PBS buffer was replaced for 6 cycles until the block gel swelled to the required weight.

[0061] (5) Then, the gel was crushed and granulated using a colloid mill at a rotation speed of 15,000 rpm and the crushing times were 2 times to obtain uniform gel particles.

[0062] (6) The sodium hyaluronate gel particles are filled into a prefilled syringe under vacuum, sterilized (121° C., 15 min) and packaged to obtain a sodium hyaluronate facial filler.

[0063] Example 2

[0064] This embodiment provides a method for preparing a high molecular weight sodium hyaluronate mesh-like ordered cross-linked facial filler, which comprises the following steps:

[0065] (1) Add 0.1 g of crosslinker 1,4-butanediol diglycidyl ether (BDDE) to 8 ml of 0.6% NaOH solution, shake thoroughly to dissolve, and then add 11% (w / w) sodium hyaluronate raw material (average molecular weight 2.8×10 6 Da), stirred until dissolved uniformly, and cross-linked at 4°C for 24h to obtain a cross-linked sodium hyaluronate gel precursor.

[0066] (2) The obtained gel precursor was fixed on a biaxial stretching machine and subjected to simultaneous biaxial stretching in the X-axis and Y-axis, wherein the stretching temperature was 8° C., the stretching rate was 10 mm / min, the stretching strain was 1000%, and the number of cycles was 50.

[0067] (3) Add 0.1 g of crosslinking agent 1,4-butanediol diglycidyl ether (BDDE) to 8 ml of 0.6% NaOH solution, shake thoroughly to dissolve, immerse the biaxially stretched gel precursor, and crosslink at 45° C. for 4 h to obtain a crosslinked sodium hyaluronate gel.

[0068] (4) Cut the cross-linked sodium hyaluronate gel into pieces less than 1 cm 3 The blocks were dialyzed by adding PBS buffer (pH 7.5) which was 80 times the weight of the gel. The dialysis was continued for 24 h and the PBS buffer was replaced for 6 cycles until the block gel swelled to the required weight.

[0069] (5) Then, the gel was crushed and granulated using a colloid mill at a rotation speed of 15,000 rpm and the crushing times were 2 times to obtain uniform gel particles.

[0070] (6) The sodium hyaluronate gel particles are filled into a prefilled syringe under vacuum, sterilized (121° C., 15 min) and packaged to obtain a sodium hyaluronate facial filler.

[0071] Example 3

[0072] This embodiment provides a method for preparing a high molecular weight sodium hyaluronate mesh-like ordered cross-linked facial filler, which comprises the following steps:

[0073] (1) Add 0.1 g of crosslinker 1,4-butanediol diglycidyl ether (BDDE) to 8 ml of 0.6% NaOH solution, shake thoroughly to dissolve, and then add 11% (w / w) sodium hyaluronate raw material (average molecular weight 2.8×10 6 Da), stirred until dissolved uniformly, and cross-linked at 4°C for 24h to obtain a cross-linked sodium hyaluronate gel precursor.

[0074] (2) The obtained gel precursor is fixed on a biaxial stretching machine and subjected to simultaneous biaxial stretching in the X-axis and Y-axis, wherein the stretching temperature is 2° C., the stretching rate is 30 mm / min, the stretching strain is 500%, and the number of cycles is 100.

[0075] (3) Add 0.1 g of crosslinking agent 1,4-butanediol diglycidyl ether (BDDE) to 8 ml of 0.6% NaOH solution, shake thoroughly to dissolve, immerse the biaxially stretched gel precursor, and crosslink at 45° C. for 4 h to obtain a crosslinked sodium hyaluronate gel.

[0076] (4) Cut the cross-linked sodium hyaluronate gel into pieces less than 1 cm 3 The blocks were dialyzed by adding PBS buffer (pH 7.5) which was 80 times the weight of the gel. The dialysis was continued for 24 h and the PBS buffer was replaced for 6 cycles until the block gel swelled to the required weight.

[0077] (5) Then, the gel was crushed and granulated using a colloid mill at a rotation speed of 15,000 rpm and the crushing times were 2 times to obtain uniform gel particles.

[0078] (6) The sodium hyaluronate gel particles are filled into a prefilled syringe under vacuum, sterilized (121° C., 15 min) and packaged to obtain a sodium hyaluronate facial filler.

[0079] Comparative Example 1 (Adjusting the stretching step to after high temperature crosslinking)

[0080] (1) Add 0.1 g of crosslinker 1,4-butanediol diglycidyl ether (BDDE) to 8 ml of 0.6% NaOH solution, shake thoroughly to dissolve, and then add 11% (w / w) sodium hyaluronate raw material (average molecular weight 2.8×10 6 Da), stirred until dissolved uniformly, and cross-linked at 4°C for 24h to obtain a cross-linked sodium hyaluronate gel precursor.

[0081] (2) 0.1 g of a crosslinking agent, 1,4-butanediol diglycidyl ether (BDDE), was added to 8 ml of a 0.6% NaOH solution, and after sufficient shaking to dissolve, the resulting gel precursor was immersed in the solution and crosslinked at 45° C. for 4 h to obtain a crosslinked sodium hyaluronate gel.

[0082] (3) The obtained gel was fixed on a biaxial stretching machine and subjected to simultaneous biaxial stretching in the X-axis and Y-axis, wherein the stretching temperature was 4° C., the stretching rate was 20 mm / min, the stretching strain was 800%, and the number of cycles was 60.

[0083] (4) Cut the cross-linked sodium hyaluronate gel into pieces less than 1 cm 3 The blocks were dialyzed by adding PBS buffer (pH 7.5) which was 80 times the weight of the gel. The dialysis was continued for 24 h and the PBS buffer was replaced for 6 cycles until the block gel swelled to the required weight.

[0084] (5) Then, the gel was crushed and granulated using a colloid mill at a rotation speed of 15,000 rpm and the crushing times were 2 times to obtain uniform gel particles.

[0085] (6) The sodium hyaluronate gel particles are filled into a prefilled syringe under vacuum, sterilized (121° C., 15 min) and packaged to obtain a sodium hyaluronate facial filler.

[0086] Comparative Example 2 (Changing the stretching temperature to room temperature)

[0087] (1) Add 0.1 g of crosslinker 1,4-butanediol diglycidyl ether (BDDE) to 8 ml of 0.6% NaOH solution, shake thoroughly to dissolve, and then add 11% (w / w) sodium hyaluronate raw material (average molecular weight 2.8×10 6 Da), stirred until dissolved uniformly, and cross-linked at 4°C for 24h to obtain a cross-linked sodium hyaluronate gel precursor.

[0088] (2) The obtained gel was fixed on a biaxial stretching machine and subjected to simultaneous biaxial stretching in the X-axis and Y-axis, wherein the stretching temperature was 25° C., the stretching rate was 20 mm / min, the stretching strain was 800%, and the number of cycles was 60.

[0089] (3) 0.1 g of a crosslinking agent, 1,4-butanediol diglycidyl ether (BDDE), was added to 8 ml of a 0.6% NaOH solution, and after sufficient shaking to dissolve, the biaxially stretched gel was immersed in the solution and crosslinked at 45° C. for 4 h to obtain a crosslinked sodium hyaluronate gel.

[0090] (4) Cut the cross-linked sodium hyaluronate gel into pieces less than 1 cm 3The blocks were dialyzed by adding PBS buffer (pH 7.5) which was 80 times the weight of the gel. The dialysis was continued for 24 h and the PBS buffer was replaced for 6 cycles until the block gel swelled to the required weight.

[0091] (5) Then, the gel was crushed and granulated using a colloid mill at a rotation speed of 15,000 rpm and the crushing times were 2 times to obtain uniform gel particles.

[0092] (6) The sodium hyaluronate gel particles are filled into a prefilled syringe under vacuum, sterilized (121° C., 15 min) and packaged to obtain a sodium hyaluronate facial filler.

[0093] Comparative Example 3 (Changing the stretching direction to X-axis unidirectional stretching)

[0094] (1) Add 0.1 g of crosslinker 1,4-butanediol diglycidyl ether (BDDE) to 8 ml of 0.6% NaOH solution, shake thoroughly to dissolve, and then add 11% (w / w) sodium hyaluronate raw material (average molecular weight 2.8×10 6 Da), stirred until dissolved uniformly, and cross-linked at 4°C for 24h to obtain a cross-linked sodium hyaluronate gel precursor.

[0095] (2) The obtained gel was fixed on a biaxial stretching machine and subjected to X-axis single-phase stretching, wherein the stretching temperature was 4° C., the stretching rate was 20 mm / min, the stretching strain was 800%, and the number of cycles was 60.

[0096] (3) 0.1 g of a crosslinking agent, 1,4-butanediol diglycidyl ether (BDDE), was added to 8 ml of a 0.6% NaOH solution, and after sufficient shaking to dissolve, the biaxially stretched gel was immersed in the solution and crosslinked at 45° C. for 4 h to obtain a crosslinked sodium hyaluronate gel.

[0097] (4) Cut the cross-linked sodium hyaluronate gel into pieces less than 1 cm 3 The blocks were dialyzed by adding PBS buffer (pH 7.5) which was 80 times the weight of the gel. The dialysis was continued for 24 h and the PBS buffer was replaced for 6 cycles until the block gel swelled to the required weight.

[0098] (5) Then, the gel was crushed and granulated using a colloid mill at a rotation speed of 15,000 rpm and the crushing times were 2 times to obtain uniform gel particles.

[0099] (6) The sodium hyaluronate gel particles are filled into a prefilled syringe under vacuum, sterilized (121° C., 15 min) and packaged to obtain a sodium hyaluronate facial filler.

[0100] Comparative Example 4 (Changing the number of stretching cycles and cyclic strain)

[0101] (1) Add 0.1 g of crosslinker 1,4-butanediol diglycidyl ether (BDDE) to 8 ml of 0.6% NaOH solution, shake thoroughly to dissolve, and then add 11% (w / w) sodium hyaluronate raw material (average molecular weight 2.8×10 6 Da), stirred until dissolved uniformly, and cross-linked at 4°C for 24h to obtain a cross-linked sodium hyaluronate gel precursor.

[0102] (2) The obtained gel was fixed on a biaxial stretching machine and subjected to simultaneous biaxial stretching in the X-axis and Y-axis, wherein the stretching temperature was 4° C., the stretching rate was 20 mm / min, the stretching strain was 400%, and the number of cycles was 200.

[0103] (3) 0.1 g of a crosslinking agent, 1,4-butanediol diglycidyl ether (BDDE), was added to 8 ml of a 0.6% NaOH solution, and after sufficient shaking to dissolve, the biaxially stretched gel was immersed in the solution and crosslinked at 45° C. for 4 h to obtain a crosslinked sodium hyaluronate gel.

[0104] (4) Cut the cross-linked sodium hyaluronate gel into pieces less than 1 cm 3 The blocks were dialyzed by adding PBS buffer (pH 7.5) which was 80 times the weight of the gel. The dialysis was continued for 24 h and the PBS buffer was replaced for 6 cycles until the block gel swelled to the required weight.

[0105] (5) Then, the gel was crushed and granulated using a colloid mill at a rotation speed of 15,000 rpm and the crushing times were 2 times to obtain uniform gel particles.

[0106] (6) The sodium hyaluronate gel particles are filled into a prefilled syringe under vacuum, sterilized (121° C., 15 min) and packaged to obtain a sodium hyaluronate facial filler.

[0107] Performance Test 1: Cohesion

[0108] Cohesion in this article refers to the degree of attraction between the cross-linked units of hyaluronic acid, reflecting the adhesion between the individual cross-linked HA units in the gel deposit. The higher the cohesion, the more the product can resist the vertical stress applied by the soft tissue, and the less likely it is to shift and collapse. Usually, cohesion can be measured indirectly by compression testing, as the resistance when compressed at a certain rate after loading on a rheometer, and its unit is gf (gram force). The test conditions are as follows:

[0109] (1) Test equipment: rotational rheometer (Anton Paar, MCR301)

[0110] (2) Gap: Initial position: 2.5 mm, Final position: 0.9 mm

[0111] (3) Speed: 0.8 mm / min

[0112] (4) Temperature: 25°C

[0113] (5) Measurement geometry: 25 mm plate

[0114] (6) Normal force measurement gap position: 1.5mm

[0115] Performance Test 2: Viscoelasticity (Storage Modulus and Loss Modulus)

[0116] In this article, viscoelasticity refers to the viscosity and elasticity of sodium hyaluronate gel after injection and filling when it is subjected to lateral shear stress such as gravity, tension, and traction of facial activities. Viscoelasticity can be evaluated by storage modulus (G') and loss elastic modulus (G"). Within a certain range, the higher the gel viscoelasticity, the better the gel support and the better the three-dimensional shaping effect. The test conditions are as follows:

[0117] (1) Test equipment: rotational rheometer (Anton Paar, MCR301)

[0118] (2) Frequency: 0.01~100Hz

[0119] (3) Strain 1%

[0120] (4) Temperature: 25°C

[0121] (5) Measurement gap: 1mm

[0122] Performance Test 3: Modification

[0123] The modification degree value is the molar ratio of the modified disaccharide units in the HA chain structure to the total disaccharide units. The modification degree measured in this study is the total modification degree (t-MOD), which is the sum of the suspension modification degree (p-MOD) and the cross-linking modification degree (c-MOD). Generally, the higher the modification degree, the longer the maintenance time in vivo.

[0124] In addition to the main product unsaturated disaccharides, the enzymatic hydrolysis products of cross-linked HA gel also contain modified fragments (oligosaccharide fragments bound to BDDE): 2-B, 4-B, 6-B (hanging modified fragments) and 2-B-2, 2-B-4 (cross-linked modified fragments). First, the cross-linked HA was fully enzymatically hydrolyzed, and then the t-MOD was determined by the normalization method based on the area in the chromatographic quantification. Enzymatic hydrolysis method: Take 2g of the sample and add 3ml of bacterial HA enzyme solution (the original enzyme solution was diluted 10 times) and mix well, and enzymolyze in a 42℃ water bath for 24h. The enzymatic hydrolysis solution was boiled for 3min, centrifuged at 25000r / min for 3min, filtered with a 0.2μm filter membrane, and diluted 10 times for chromatographic analysis.

[0125] Performance Test 4: In vitro degradation rate

[0126] Although the in vitro enzymatic hydrolysis properties cannot fully reflect the in vivo maintenance time (the in vivo maintenance time is affected by many factors such as injection depth and blood flow at the injection site), it has certain guiding significance for predicting the in vivo maintenance time under the same indication. The lower the degradation rate of the gel, the stronger the resistance to hyaluronidase, and the longer the maintenance time after injection into the human body. The test conditions are as follows: Take 50 mg of cross-linked hyaluronic acid gel, immerse it completely in 1 ml 25-100 U / mL bovine testicular hyaluronidase solution, and shake it at 37 ° C. After the reaction is completed, place it in a water bath and boil for 15 minutes, centrifuge it at 10000 rpm for 20 minutes, and take 500 μl of supernatant. The supernatant is diluted 20 times with deionized water, and the glucuronic acid content can be analyzed by carbazole colorimetric method. The degradation rate is calculated by comparing the glucuronic acid content measured at different time points.

[0127] Table 1

[0128]

[0129] Table 1 shows that the stretching conditions such as cross-linking order, stretching direction, stretching temperature, stretching rate and strain in the present invention all have an impact on the final index, among which the influence of the order of "low temperature cross-linking-mechanical stretching-high temperature cross-linking" is more prominent. In Comparative Example 1, after the mechanical stretching order is moved to high temperature cross-linking, the viscoelasticity, cohesion, modification degree and degradation performance of the obtained gel are greatly reduced. It is not desirable to be bound by theory, which may be due to the covalent bonding of a large number of hyaluronic acid molecular chains with cross-linking agent molecules during high temperature cross-linking, and a dense disordered three-dimensional network structure has been fully formed in the gel. At this time, it is impossible to induce the hyaluronic acid molecular chains to be arranged regularly along the force direction by mechanical external force, thereby causing the gel network structure to be messy and uneven. In addition, compared with the stretching conditions in Examples 1-3, increasing the stretching temperature (Comparative Example 2), changing the stretching direction to unidirectional (Comparative Example 3), reducing the stretching strain (Comparative Example 4), reducing the number of cycles and reducing the stretching rate will all weaken the induction effect of external mechanical force on the orderly arrangement of hyaluronic acid molecular chains along the force direction, resulting in a decrease in the viscoelasticity, cohesion, degree of modification and degradation performance of the gel, thereby affecting the clinical use effect of the product.

[0130] Comprehensively considering various indicators, it is found that the present invention performs biaxial mechanical stretching between low-temperature and high-temperature cross-linking, which promotes the preferential orientation of the internal molecular chains of the hydrogel along the force direction, and then makes the sodium hyaluronate molecular chains oriented along the X-axis and the Y-axis cross-arrange to form an ordered grid, so that it has higher viscoelasticity, cohesion, modification degree and degradation performance, ensuring that the product has a more natural and lasting filling effect.

Claims

1. A method for preparing a sodium hyaluronate facial filler, comprising the following steps: (1) reacting a sodium hyaluronate raw material with a first cross-linking agent in an alkaline solution at low temperature to obtain a gel precursor; (2) performing biaxial mechanical stretching on the gel precursor in both the X-axis and the Y-axis to obtain a gridded gel precursor; (3) reacting the gridded gel precursor with a second cross-linking agent in an alkaline solution at high temperature to obtain a sodium hyaluronate gel; The mechanical stretching is carried out at a stretching temperature of 2-8°C; The mechanical stretching is carried out at a stretching rate of 10-30 mm / min; The mechanical stretching is performed at a tensile strain of 500%-1000%; The mechanical stretching is performed 50-100 times.

2. The method according to claim 1, wherein: The low temperature is 2-8°C.

3. The method according to claim 1, wherein: The high temperature is 30-50°C.

4. The method according to claim 1, wherein: The first crosslinking agent and the second crosslinking agent are each independently selected from one or more of glutaraldehyde, divinyl sulfone, 1,4-butanediol diglycidyl ether, 1,2,7,8-diepoxyoctane and carbodiimide.

5. The method according to claim 1, wherein: The molecular weight of the sodium hyaluronate raw material is 2.0×10 6 Da-4.0×10 6 Da.

6. The method according to claim 1, wherein: The weight of the sodium hyaluronate raw material accounts for 5-20% of the total weight of the reaction system in step (1).

7. The method according to claim 1, wherein: The reaction in step (1) is carried out for 2-24 hours.

8. The method according to claim 1, wherein: The pH of the alkaline solution in step (1) is greater than 10.

9. The method according to claim 1, wherein: The reaction in step (3) is carried out for 0.5-10 hours.

10. The method according to claim 1, wherein: The pH of the alkaline solution in step (3) is greater than 10.

11. The method according to claim 1, wherein: The method further comprises the step (4) after the step (3): The sodium hyaluronate gel obtained in step (3) is cut into block gels and added into PBS buffer or physiological saline for cyclic dialysis.

12. The method according to claim 11, wherein: The method further comprises the step (5) after the step (4): The dialyzed block gel obtained in step (4) is crushed and granulated to obtain sodium hyaluronate gel particles.

13. The method according to claim 12, wherein: The method further comprises a step (6) after step (5): filling the sodium hyaluronate gel particles obtained in step (5) into a prefilled syringe under vacuum.

14. The method according to claim 13, wherein: The method further comprises a step (7) after step (6): sterilizing and packaging the product obtained in step (6) to obtain a sodium hyaluronate facial filler.

15. A sodium hyaluronate facial filler prepared by the method of any one of claims 1 to 14.

Citation Information

Patent Citations

  • Unidirectional fibrous cross-linked sodium hyaluronate dermal implant and preparation method thereof

    CN115252895A